These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 23039216)

  • 41. Assessing potential glycemic overtreatment in persons at hypoglycemic risk.
    Tseng CL; Soroka O; Maney M; Aron DC; Pogach LM
    JAMA Intern Med; 2014 Feb; 174(2):259-68. PubMed ID: 24322626
    [TBL] [Abstract][Full Text] [Related]  

  • 42. High daily insulin exposure in patients with type 2 diabetes is associated with increased risk of cardiovascular events.
    Stoekenbroek RM; Rensing KL; Bernelot Moens SJ; Nieuwdorp M; DeVries JH; Zwinderman AH; Stroes ES; Currie CJ; Hutten BA
    Atherosclerosis; 2015 Jun; 240(2):318-23. PubMed ID: 25864162
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Frequency and awareness of hypoglycemia in patients with Type 2 Diabetes treated with two or more insulin injections in primary care outpatient clinics.
    Cabré C; Colungo C; Vinagre I; Jansà M; Conget I
    Prim Care Diabetes; 2020 Apr; 14(2):168-172. PubMed ID: 31474469
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Incidence, characteristics and impact of hypoglycaemia in patients receiving intensified treatment for inadequately controlled type 2 diabetes mellitus.
    Tschöpe D; Bramlage P; Schneider S; Gitt AK
    Diab Vasc Dis Res; 2016 Jan; 13(1):2-12. PubMed ID: 26567123
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Relationship between glycated hemoglobin level and duration of hypoglycemia in type 2 diabetes patients treated with sulfonylureas: A multicenter cross-sectional study.
    Matsuoka A; Hirota Y; Takeda A; Kishi M; Hashimoto N; Ohara T; Higo S; Yamada H; Nakamura T; Hamaguchi T; Takeuchi T; Nakagawa Y; Okada Y; Sakaguchi K; Ogawa W
    J Diabetes Investig; 2020 Mar; 11(2):417-425. PubMed ID: 31461223
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Rate of hypoglycemia in insulin-treated patients with type 2 diabetes can be predicted from glycemic variability data.
    Qu Y; Jacober SJ; Zhang Q; Wolka LL; DeVries JH
    Diabetes Technol Ther; 2012 Nov; 14(11):1008-12. PubMed ID: 23101951
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Association of Cumulative Multimorbidity, Glycemic Control, and Medication Use With Hypoglycemia-Related Emergency Department Visits and Hospitalizations Among Adults With Diabetes.
    McCoy RG; Lipska KJ; Van Houten HK; Shah ND
    JAMA Netw Open; 2020 Jan; 3(1):e1919099. PubMed ID: 31922562
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Unrecognized hypo- and hyperglycemia in well-controlled patients with type 2 diabetes mellitus: the results of continuous glucose monitoring.
    Hay LC; Wilmshurst EG; Fulcher G
    Diabetes Technol Ther; 2003; 5(1):19-26. PubMed ID: 12725703
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Be Careful What You Ask For: Effects of Benefit Descriptions on Diabetes Patients' Benefit-Risk Tradeoff Preferences.
    von Arx LB; Johnson FR; Mørkbak MR; Kjær T
    Value Health; 2017 Apr; 20(4):670-678. PubMed ID: 28408010
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A retrospective cross-sectional study of type 2 diabetes overtreatment in patients admitted to the geriatric ward.
    Wojszel ZB; Kasiukiewicz A
    BMC Geriatr; 2019 Sep; 19(1):242. PubMed ID: 31477024
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Understanding drug preferences, different perspectives.
    Mol PG; Arnardottir AH; Straus SM; de Graeff PA; Haaijer-Ruskamp FM; Quik EH; Krabbe PF; Denig P
    Br J Clin Pharmacol; 2015 Jun; 79(6):978-87. PubMed ID: 25469876
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Depression in Chinese patients with type 2 diabetes: associations with hyperglycemia, hypoglycemia, and poor treatment adherence.
    Zhang Y; Ting RZ; Yang W; Jia W; Li W; Ji L; Guo X; Kong AP; Wing YK; Luk AO; Sartorius N; Morisky DE; Oldenburg B; Weng J; Chan JC;
    J Diabetes; 2015 Nov; 7(6):800-8. PubMed ID: 25349949
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Characteristics of Patients with Type-1 or Type-2 Diabetes Receiving Insulin Glargine U300: An Analysis of 7268 Patients Based on the DPV and DIVE Registries.
    van Mark G; Lanzinger S; Sziegoleit S; Putz FJ; Durmaz M; Borscheller M; Danne T; Seufert J; Holl RW; Bramlage P
    Adv Ther; 2019 Jul; 36(7):1628-1641. PubMed ID: 31119688
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Efficacy of self-monitoring of blood glucose versus retrospective continuous glucose monitoring in improving glycaemic control in diabetic kidney disease patients.
    Yeoh E; Lim BK; Fun S; Tong J; Yeoh LY; Sum CF; Subramaniam T; Lim SC
    Nephrology (Carlton); 2018 Mar; 23(3):264-268. PubMed ID: 27933715
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Hypoglycemia in patients with type 2 diabetes treated with oral antihyperglycemic agents detected by continuous glucose monitoring: a multi-center prospective observational study in Croatia.
    Baretić M; Bralić Lang V
    BMC Endocr Disord; 2020 Mar; 20(1):35. PubMed ID: 32151247
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Mealtime 50/50 basal + prandial insulin analogue mixture with a basal insulin analogue, both plus metformin, in the achievement of target HbA1c and pre- and postprandial blood glucose levels in patients with type 2 diabetes: a multinational, 24-week, randomized, open-label, parallel-group comparison.
    Robbins DC; Beisswenger PJ; Ceriello A; Goldberg RB; Moses RG; Pagkalos EM; Milicevic Z; Jones CA; Sarwat S; Tan MH
    Clin Ther; 2007 Nov; 29(11):2349-64. PubMed ID: 18158076
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Assessment of baseline characteristics, glycemic control and oral antidiabetic treatment in Asian patients with diabetes: The Registry for Assessing OAD Usage in Diabetes Management (REASON) Asia study.
    Vichayanrat A; Matawaran BJ; Wibudi A; Ferdous HS; Aamir AH; Aggarwal SK; Bajpai S
    J Diabetes; 2013 Sep; 5(3):309-18. PubMed ID: 23462227
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Efficacy, safety and acceptability of biphasic insulin aspart 30 in Indian patients with type 2 diabetes: results from the PRESENT study.
    Sharma SK; Joshi SR; Kumar A; Unnikrishnan AG; Hoskote SS; Moharana AK; Chakkarwar PN; Vaz JA;
    J Assoc Physicians India; 2008 Nov; 56():859-63. PubMed ID: 19263683
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Low-volume insulin degludec 200 units/ml once daily improves glycemic control similarly to insulin glargine with a low risk of hypoglycemia in insulin-naive patients with type 2 diabetes: a 26-week, randomized, controlled, multinational, treat-to-target trial: the BEGIN LOW VOLUME trial.
    Gough SC; Bhargava A; Jain R; Mersebach H; Rasmussen S; Bergenstal RM
    Diabetes Care; 2013 Sep; 36(9):2536-42. PubMed ID: 23715753
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Hypoglycemia in patients with type 2 diabetes from India and Malaysia treated with sitagliptin or a sulfonylurea during Ramadan: a randomized, pragmatic study.
    Aravind SR; Ismail SB; Balamurugan R; Gupta JB; Wadhwa T; Loh SM; Suryawanshi S; Davies MJ; Girman CJ; Katzeff HL; Radican L; Engel SS; Wolthers T
    Curr Med Res Opin; 2012 Aug; 28(8):1289-96. PubMed ID: 22738801
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.